bf/NASDAQ:PHIO_icon.jpeg

COM:PHIOPHARMA

Phio Pharmaceuticals

  • Stock

Last Close

2.38

21/11 20:54

Market Cap

3.15M

Beta: -

Volume Today

32.56K

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    phiopharma.com/
  • ipo date

    May 10, 2012

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy i...Show More

peer of